In this episode, Ginger Vieira looks at the latest technology in CGM and what it means for diabetes care during pregnancy.She is joined by Dr Denice Feig to discuss the latest research and trends in CGM during pregnancy.They discuss:How CGM improves maternal and neonatal outcomesKey clinical trials including the CONCEPTT trialEvolving trends in CGM use across different types of diabetes in pregnancy (T1D, T2D, GDM)Dr Denice Feig is a Professor of Medicine in the Division of Endocrinology and Metabolism at the University of Toronto. She is a Senior Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute, and an Adjunct Scientist at ICES. Dr Feig is also the Head of Diabetes and Endocrinology in the Pregnancy Program at Mount Sinai Hospital.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
-------- Â
16:00
--------
16:00
The Future of AI-Driven CGM in Diabetes & Metabolic Health
In this episode, Dr David Kerr continues his look at AI-driven CGM tools and the future of diabetes and metabolic health. He’s joined by Stanford W. Ascherman Professor of Genetics, Dr Michael Snyder to hear the latest on emerging technologies, and the shift towards integrative and personalised healthcare.They discuss:How AI and CGM technology is transforming diabetes and metabolic health managementAI identification of diabetes subtypes and personalised interventionsImpact of physical activity, sleep, and stress on glucose levels, as well as the emerging role of gut microbiome health in metabolic wellnessPotential of AI-driven tools for early intervention and improved health outcomesDr Snyder is the Stanford W. Ascherman Professor of Genetics and Director at the Stanford Center of Genomics and Personalized Medicine. He is a leader in the field of functional genomics and proteomics, and co-founder of many biotechnology companies, including Personalis, SensOmics, Qbio @qbioinc, January AI, Filtricine, Mirvie, and Protos.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
-------- Â
23:20
--------
23:20
AI-Driven CGM & Personalized Medicine
In the first episode of our new series CGM in Focus, supported by Dexcom, host Dr David Kerr takes a closer look at AI-Driven CGM, its impact on the latest technology in continuous glucose monitoring, and what it means in practice for clinicians and patients alike.To discuss this exciting topic, Dr Kerr is joined by Consultant Physician in Metabolic Medicine, Dr Shivani Misra.They cover:The Role of AI in Continuous Glucose MonitoringChallenges and Potential of AI in Diabetes ManagementAI and CGM for Young People with DiabetesPotential for AI to instigate behaviour changeDr Shivani Misra is a Consultant Physician in Metabolic Medicine, a Wellcome Trust-funded investigator, and Head of Metabolic Medicine at Imperial College London. Dr Misra specialises in early-onset type 2 diabetes, atypical and non-classical diabetes phenotypes, and congenital hyperinsulinism.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
-------- Â
19:16
--------
19:16
Common Questions Answered; Advancing Long-Acting Insulin in Practice
In the final episode of our series on Long-Acting Insulin, host Ginger Vieira is joined by David Ahn, MD to answer key questions from fellow clinicians and listeners.They explore a wide range of topics including:General challenges in managing diabetesAdjusting insulin doses for better controlTime in tight range (TITR) and insulin managementFasting and diabetes managementImpact of GLP-1 on Type 1 diabetes managementChallenges of switching to weekly insulin injectionsDefining and managing hypoglycemia riskPersonalized diabetes management approachesDiabetes management in athletesDr David Ahn is Program Director and Kris V. Iyer Endowed Chair in Diabetes Care at the Mary and Dick Allen Diabetes Center in Newport Beach, CA. Dr Ahn is a leading digital health speaker, writer, and innovator, and currently serves as the Technology Blog Editor for the nonprofit organization, Taking Control of Your Diabetes.Visit the Insulin Knowledge Hub on the ATTD Education Portal for further resources and in-depth content on long-acting insulin therapy.Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
-------- Â
47:18
--------
47:18
Real-World Applications and Success Stories
In today’s episode, host Ginger Vieira is joined by two patients – one with Type 1 and one with Type 2 diabetes – to share their experiences with long-acting insulin.They cover:Challenges and solutions in real-world insulin therapyHow personalized strategies improve patient outcomesLessons learned from patient-provider collaborationsFuture opportunities for enhancing patient engagement and adherenceHow to balance diabetes care with lifestyle choicesChristel Oerum is the founder of Diabetes Strong, which provides information about diabetes by people living with the condition. She has lived with Type 1 diabetes since 1997.Real Prince Blue is a podcast host who has lived with Type 2 diabetes since 2016. A retired cop and army vet, Prince documents his fitness journey on social media. Prince recently finished his doctorate in criminal justice.Visit the Insulin Knowledge Hub on the ATTD Education Portal for further resources and in-depth content on long-acting insulin therapy.Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
About ATTD: Advanced Technologies and Treatments for Diabetes
ATTD is the ultimate forum for the latest in diabetes research, technology, and clinical innovation. This podcast channel offers two types of content designed for busy healthcare professionals:
* ATTD Conference Catch-up: Short, AI-generated episodes with key insights from expert presentations & research discussions at the ATTD Conference.
* Curated Series: In-depth, human-led conversations such as our current CGM in Focus series, supported by Dexcom, and previously Long-Acting Insulin Uncovered supported by Eli Lily.
Whether you're a specialist, researcher, or industry leader, hit subscribe.
Listen to ATTD: Advanced Technologies and Treatments for Diabetes, Boring History for Sleep and many other podcasts from around the world with the radio.net app
Ireland